Alireza Nami is a Rheumatology/Immunology physician affiliated with Joint Muscle Medical Care and Research Institute. OpenAlex indexes 6 publications with 1,053 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
1 company with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
49.3%RANK Ligand Inhibitor36.2%Denosumab99%Prolia1%Part D + Part B≥32 patientsCentral alpha-2 Adrenergic Agonist5%Tizanidine Hcl100%Part D≥106 patients+ 7 more classes in this area
Nervous system
19.6%Gabapentinoids7.4%Gabapentin70%Pregabalin30%Part D≥113 patientsSNRI6.3%Duloxetine Hcl100%Part D≥146 patients+ 10 more classes in this area
Cancer & immunology
13.5%Folate Analog Metabolic Inhibitor8.4%Methotrexate sodium47%Methotrexate45%Rasuvo3%Otrexup3%Methotrexate Sodium2%Part D + Part B<11 patientsAntirheumatic Agent1.3%Leflunomide100%Part D≥30 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
David J. Hunter
The University of Sydney
Aziz Sheikh
Universiti Malaysia Terengganu
Nima Hafezi‐Nejad
The University of Sydney
Gelin Xu
Second Affiliated Hospital of Nanjing Medical University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”